FDA's Label Directive Pumps Up Plaintiffs In Drug Suits

Law360, New York (February 6, 2013, 9:22 PM EST) -- The U.S. Food and Drug Administration might have unwittingly handed plaintiffs an attractive new weapon in failure-to-warn litigation against drugmakers when it revealed Tuesday that most prescription drugs do not adhere to the format changes laid out in a 2006 labeling rule, attorneys say.

In a notice, the FDA told drugmakers it would help them convert their product labels to the format in the so-called physician labeling rule — a 2006 regulation designed to make drug warnings easier for physicians to read and focus labels on...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.